PerkinElmer recently discussed next-generation cancer therapies with one of the founders of the field, Dr. Sunil Chada. The complexity of cancer continues to pose significant challenges for researchers in the development of novel therapeutic agents. Historic treatment approaches including chemotherapy, radiation, and immunotherapies such as antibody therapies have failed to deliver curative outcomes for most …